MEP0208A - Aptameri koji vezuje trombin sa visokim afininitetom - Google Patents
Aptameri koji vezuje trombin sa visokim afininitetomInfo
- Publication number
- MEP0208A MEP0208A MEP-02/08A MEP0208A MEP0208A ME P0208 A MEP0208 A ME P0208A ME P0208 A MEP0208 A ME P0208A ME P0208 A MEP0208 A ME P0208A
- Authority
- ME
- Montenegro
- Prior art keywords
- aptamers
- thrombin
- high affinity
- bind thrombin
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71176805P | 2005-08-26 | 2005-08-26 | |
US80859006P | 2006-05-26 | 2006-05-26 | |
PCT/US2006/033092 WO2007025049A2 (en) | 2005-08-26 | 2006-08-23 | Aptamers that bind thrombin with high affinity |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP0208A true MEP0208A (xx) | 2010-02-10 |
Family
ID=37772390
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2008-2A ME00016B (me) | 2005-08-26 | 2006-08-23 | Aptameri koji vezuje trombin sa visokim afininitetom |
MEP-02/08A MEP0208A (xx) | 2005-08-26 | 2006-08-23 | Aptameri koji vezuje trombin sa visokim afininitetom |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2008-2A ME00016B (me) | 2005-08-26 | 2006-08-23 | Aptameri koji vezuje trombin sa visokim afininitetom |
Country Status (12)
Country | Link |
---|---|
US (2) | US7998939B2 (xx) |
EP (1) | EP1928505A4 (xx) |
JP (1) | JP2009508473A (xx) |
KR (1) | KR20080042091A (xx) |
AU (1) | AU2006283025A1 (xx) |
BR (1) | BRPI0614961A2 (xx) |
CA (1) | CA2617782A1 (xx) |
EA (1) | EA200800667A1 (xx) |
IL (1) | IL188797A0 (xx) |
ME (2) | ME00016B (xx) |
RS (1) | RS20080075A (xx) |
WO (1) | WO2007025049A2 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008134069A2 (en) * | 2007-04-26 | 2008-11-06 | University Of Florida Research Foundation | Anchored ligand agents |
WO2009149921A2 (en) * | 2008-06-11 | 2009-12-17 | Bionucleon S.R.L. | Inhibition of hrp-3 using modified oligonucleotides |
WO2010033167A2 (en) * | 2008-09-18 | 2010-03-25 | Archemix Corp. | Anti-thrombin aptamer formulations and methods for use |
EP2497828A1 (en) * | 2011-03-07 | 2012-09-12 | Charité - Universitätsmedizin Berlin | Use of aptamers in therapy and/or diagnosis of autoimmune diseases |
FR2983212A1 (fr) * | 2011-11-28 | 2013-05-31 | Lfb Biotechnologies | Aptameres anti-fh, procede pour leur obtention et utilisations |
GB201121513D0 (en) | 2011-12-14 | 2012-01-25 | Cambridge Entpr Ltd | Thrombin-binding antibody molecules and uses thereof |
US9518128B2 (en) | 2011-12-14 | 2016-12-13 | Janssen Pharmaceuticals, Inc. | Thrombin-binding antibody molecules |
CN104661664B (zh) | 2012-07-13 | 2020-07-03 | 波涛生命科学有限公司 | 手性控制 |
US10231993B2 (en) * | 2013-06-27 | 2019-03-19 | University Of Washington Through Its Center For Commercialization | Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders |
BR102013021701A2 (pt) | 2013-08-26 | 2015-07-28 | Univ São Paulo Usp | Polinucleotídeos quimicamente modificados e processo de produção de polinucleotídeos quimicamente modificados |
CA2956718A1 (en) * | 2014-07-31 | 2016-02-04 | Academia Sinica | An antagonistic pd-1 aptamer and its applications in cancer therapy related applications |
EP2982756A1 (en) | 2014-08-04 | 2016-02-10 | Berlin Cures Holding AG | Aptamers for use against autoantibody-associated diseases |
IL234246A0 (en) | 2014-08-21 | 2014-11-30 | Omrix Biopharmaceuticals Ltd | Stabilized thrombin |
WO2019030706A1 (en) | 2017-08-10 | 2019-02-14 | Janssen Pharmaceutica Nv | ANTI-THROMBIN ANTIBODY MOLECULES AND METHODS OF USE IN ORTHOPEDIC SURGERY |
WO2019035055A1 (en) | 2017-08-16 | 2019-02-21 | Janssen Pharmaceutica Nv | ANTI-THROMBIN ANTIBODY MOLECULES AND METHODS OF USE WITH PLATELET ANTI-AGGREGATE AGENTS |
EP4069363A1 (en) * | 2019-12-04 | 2022-10-12 | Duke University | Methods for controlling extracorporeal membrane oxygenation (ecmo) coagulation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1456092A (en) | 1991-02-21 | 1992-09-15 | Gilead Sciences, Inc. | Aptamers specific for thrombin and methods of use |
US5756291A (en) * | 1992-08-21 | 1998-05-26 | Gilead Sciences, Inc. | Aptamers specific for biomolecules and methods of making |
JPH10510540A (ja) * | 1994-12-12 | 1998-10-13 | オメロス メディカル システムズ,インコーポレーテッド | 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法 |
US20030054360A1 (en) * | 1999-01-19 | 2003-03-20 | Larry Gold | Method and apparatus for the automated generation of nucleic acid ligands |
CA2476309A1 (en) * | 2002-02-15 | 2003-08-28 | Somalogic, Inc. | Methods and reagents for detecting target binding by nucleic acid ligands |
US20050037394A1 (en) | 2002-12-03 | 2005-02-17 | Keefe Anthony D. | Method for in vitro selection of 2'-substituted nucleic acids |
WO2004050899A2 (en) * | 2002-12-03 | 2004-06-17 | Archemix Corporation | Method for in vitro selection of 2’-substituted nucleic acids |
CA2545006C (en) * | 2003-12-12 | 2013-09-17 | Saint Louis University | Biosensors for detecting macromolecules and other analytes |
US20090215873A1 (en) | 2005-09-29 | 2009-08-27 | Andrew Vaillant | Therapeutic Molecules and their Uses |
AU2006302022A1 (en) | 2005-10-06 | 2007-04-19 | University Of Delaware | G-rich polynucleotides for the treatment of Huntington's Disease |
-
2006
- 2006-08-23 BR BRPI0614961A patent/BRPI0614961A2/pt not_active IP Right Cessation
- 2006-08-23 EA EA200800667A patent/EA200800667A1/ru unknown
- 2006-08-23 AU AU2006283025A patent/AU2006283025A1/en not_active Abandoned
- 2006-08-23 RS RSP-2008/0075A patent/RS20080075A/sr unknown
- 2006-08-23 ME MEP-2008-2A patent/ME00016B/me unknown
- 2006-08-23 CA CA002617782A patent/CA2617782A1/en not_active Abandoned
- 2006-08-23 US US11/990,998 patent/US7998939B2/en not_active Expired - Fee Related
- 2006-08-23 KR KR1020087004141A patent/KR20080042091A/ko not_active Application Discontinuation
- 2006-08-23 EP EP06813718A patent/EP1928505A4/en not_active Withdrawn
- 2006-08-23 JP JP2008528152A patent/JP2009508473A/ja active Pending
- 2006-08-23 ME MEP-02/08A patent/MEP0208A/xx unknown
- 2006-08-23 WO PCT/US2006/033092 patent/WO2007025049A2/en active Application Filing
-
2008
- 2008-01-15 IL IL188797A patent/IL188797A0/en unknown
-
2011
- 2011-08-15 US US13/209,800 patent/US20120149764A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0614961A2 (pt) | 2016-09-13 |
EP1928505A2 (en) | 2008-06-11 |
JP2009508473A (ja) | 2009-03-05 |
EA200800667A1 (ru) | 2008-08-29 |
WO2007025049A2 (en) | 2007-03-01 |
RS20080075A (xx) | 2009-07-15 |
US20090221680A1 (en) | 2009-09-03 |
US20120149764A1 (en) | 2012-06-14 |
AU2006283025A1 (en) | 2007-03-01 |
US7998939B2 (en) | 2011-08-16 |
CA2617782A1 (en) | 2007-03-01 |
WO2007025049A3 (en) | 2009-04-16 |
EP1928505A4 (en) | 2010-10-27 |
IL188797A0 (en) | 2008-08-07 |
KR20080042091A (ko) | 2008-05-14 |
ME00016B (me) | 2010-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20080075A (xx) | Aptameri koji vezuju trombin sa visokim afinitetom | |
TW200740849A (en) | Dual variable domain immunoglobulin and uses thereof | |
TW200745163A (en) | Peptides that block the binding of IgG to FcRn | |
PH12015500093A1 (en) | Il-17 binding proteins | |
WO2006033854A3 (en) | Aptamers to von willebrand factor and their use as thrombotic disease therapeutics | |
MX2010008688A (es) | Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria. | |
MX2007009807A (es) | Agentes terapeuticos de aptameros utiles en el tratamiento de trastornos relacionados con el complemento. | |
MXPA06014510A (es) | Composiciones y metodos para tratar trastornos inflamatorios. | |
WO2008024188A3 (en) | Dual variable domain immunoglobulin and uses thereof | |
PH12015500576A1 (en) | Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases | |
EA201270528A1 (ru) | Композиции цитокинов семейства il-17 и их применение | |
MX2010011957A (es) | Moleculas de union basadas en fibronectina mejoradas y usos de las mismas. | |
WO2018191548A3 (en) | Complement factor d antagonist antibodies and conjugates thereof | |
WO2010045388A3 (en) | Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis | |
MX2009008104A (es) | Hepcidina, antagonistas de hepcidina y metodos de uso. | |
WO2010033279A3 (en) | Antibodies with altered binding to fcrn and methods of using same | |
MY162511A (en) | Engineered anti-tslp antibody | |
MX2012000396A (es) | Metodos y composiciones para uso en tartamientos celulares. | |
NO20091181L (no) | Anti-C5AR-antistoffer med forbedrede egenskaper | |
WO2009102438A3 (en) | Aptamer inhibitors of osteopontin and methods of use thereof | |
WO2006096222A3 (en) | Nucleic acid ligands specific to immunoglobulin e and their use as atopic disease therapeutics | |
WO2010091396A3 (en) | Aptamers to von willerbrand factor and their use as thrombotic, hematologic and cardiovascular disease therapeutics | |
ZA200801457B (en) | Aptamers that bind thrombin with high affinity | |
WO2007011765A3 (en) | Methods of identifying and treating individuals exhibiting mutant src kinase polypeptides | |
WO2005113813A8 (en) | Nucleic acid ligands specific to immunoglobulin e and their use as atopic disease therapeutics |